# Enjamb Labs Growth Score: 74/100

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-p26/enjamb-labs
Source observed: 2026-09-30T02:39:35.252Z
Last checked: 2026-10-17T08:55:20.436+00:00
Indexed: 2026-09-30T06:52:11.779+00:00

---

# Enjamb Labs landing-page report

We analyze the public landing page at [enjamb.ai](https://www.enjamb.ai/) for Lazyweb’s YC P26 Growth Score. Our weakest category is **Value props**.

## Overall score and ranking

- **Growth score:** 74/100
- **Updated:** September 20, 2026
- **Weakest category:** Value props
- **Category scores:** Value props 64, CTA 72, Trust 76, Mobile web 78, Information hierarchy 82

Among the compared sites:

1. Enjamb Labs — 74
2. [Yseop — 73](https://www.lazyweb.com/growth-score/site/yseop.com)
3. [TrialKey/Sorcero alternative — Vivodyne excluded; use DeepCure excluded — 73](https://www.lazyweb.com/growth-score/site/novo.ai)
4. [Weave Bio — 66](https://www.lazyweb.com/growth-score/site/weave.bio)
5. [Certara (CoAuthor) — 58](https://www.lazyweb.com/growth-score/site/certara.com)

[Fix Value props](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Value props — 64/100, Fair

Our headline and subhead are:

> **“AI Workforce for Biopharma”**
>
> “The world's largest pharmaceutical companies trust Enjamb with the work that brings a drug to market.”

### Working

- Names the vertical instantly.
- The trust claim is supported by visible pharma logos.
- Frames an outcome: bringing a drug to market.

### Could improve

- The page does not say what work the AI performs.
- No numbers appear in the fold.
- The hero image decorates rather than demonstrates.

Value-proposition ranking: Yseop 78, TrialKey/Sorcero alternative — Vivodyne excluded; use DeepCure excluded 70, Enjamb Labs 64, Weave Bio 62, Certara (CoAuthor) 58.

## CTA — 72/100, Fair

Our primary CTA is **“Book a demo.”** The report identifies these problems:

- The demo click feels costly or committal.
- There is no low-commitment alternative path.
- The button is smaller than the headline’s visual presence.

CTA ranking: Enjamb Labs 72, TrialKey/Sorcero alternative — Vivodyne excluded; use DeepCure excluded 72, Yseop 63, Weave Bio 62, Certara (CoAuthor) 62.

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=enjamb.ai#opt-cta-writing)

## Trust — 76/100, Fair

Trust measures proof that a product is real, competent, and safe to try.

| Site | Trust read |
|---|---|
| Enjamb Labs | Logo strip with Merck, Sanofi, Bristol Myers Squibb, Johnson & Johnson, Stanford, and MIT |
| Yseop | Customer logo strip: Bayer, GSK, Lilly, Novartis, Pierre Fabre, Sanofi |
| Weave Bio | Press Release: Weave Bio Announces Collaboration with Takeda |
| Certara (CoAuthor) | “Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit” news card |
| TrialKey/Sorcero alternative — Vivodyne excluded; use DeepCure excluded | “Trusted by 250,000+ independent businesses” ticker above the headline |

Trust ranking: Enjamb Labs 76, Yseop 72, TrialKey/Sorcero alternative — Vivodyne excluded; use DeepCure excluded 62, Weave Bio 58, Certara (CoAuthor) 44.

[Build proof section](https://www.lazyweb.com/backlog?site=enjamb.ai#opt-trust-signals)

## Mobile web — 78/100, Fair

![Mobile web annotations](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/enjamb.ai-mobile.jpg?v=2026-09-20T08%3A29%3A51.076%2B00%3A00)

1. **Book a demo button:** A desktop-proportioned button occupies about one-third of the column instead of using a thumb-friendly full-bleed treatment.
2. **YC announcement bar:** A sticky promotional strip above the header consumes fold height without a conversion-focused CTA.
3. **Faded logo strip:** Sanofi and Bristol Myers Squibb logos have low contrast against the dark image, weakening the trust signal.

[View mobile fixes](https://www.lazyweb.com/backlog?site=enjamb.ai#opt-mobile-web)

## Information hierarchy — 82/100, Strong

![Information hierarchy annotations](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/enjamb.ai.jpg?v=2026-09-20T08%3A29%3A51.076%2B00%3A00)

1. **YC announcement banner:** It sits above the logo and headline with a “Read more” exit link, taking the first scan before the value proposition lands.
2. **Five-group navigation row:** Platform, Solutions, Security, Blog, and Company plus dropdowns create seven leak points before the demo CTA.
3. **Login button:** Boxed styling competes visually with the adjacent “Book a demo” primary.

## Competitors

These competitors are inferred from product, audience, and value proposition:

1. Enjamb Labs — 74
2. [Yseop — yseop.com — 73](https://www.lazyweb.com/growth-score/site/yseop.com)
3. [TrialKey/Sorcero alternative — Vivodyne excluded; use DeepCure excluded — novo.ai — 73](https://www.lazyweb.com/growth-score/site/novo.ai)
4. [Weave Bio — weave.bio — 66](https://www.lazyweb.com/growth-score/site/weave.bio)
5. [Certara (CoAuthor) — certara.com — 58](https://www.lazyweb.com/growth-score/site/certara.com)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-p26%2Fenjamb-labs&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-p26%2Fenjamb-labs). Opening a form does not execute a tool.